Announcements
MiraVista Institutional Biosafety Committee (IBC) Announcement
In compliance with NIAID/NIH guidelines, research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →
American College of Chest Physicians Boston, MA October 6-9, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT This event will bring you the most up-to-date education in clinical pulmonary, critical care,…
READ MORE →
ID WEEK Los Angeles, CA October 16-20, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT Surround yourself with the ID experts who are advancing the field of ID. Choose scientific programming that’s…
READ MORE →
MiraVista Institutional Biosafety Committee (IBC) Announcement
In compliance with NIAID/NIH guidelines research at MiraVista Diagnostics utilizing synthetic or recombinant DNA is annually reviewed by the MiraVista Institutional Biosafety Committee (IBC). The IBC is made up of internal and external subject matter experts to ensure that MiraVista…
READ MORE →
Pulmonary Histoplasmosis: A Clinical Update – Published
MiraVista Diagnostics’ article “Pulmonary Histoplasmosis: A Clinical Update” has been published in “Journal of Fungi” as part of the Special Issue “Diagnosis and Treatment of Invasive Pulmonary Fungal Infections.” Read the article. View the PDF.
PAST EVENT: American Transplant Congress 2024 Philadelphia, PA June 1-5, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT The American Transplant Congress (ATC) brings together the people and organizations who are redefining the…
READ MORE →
PAST EVENT: Coccidioides Study Group San Antonio, TX April 5-6, 2024
MIRAVISTA DIAGNOSTICS WILL BE AT THIS EVENT The 68th Annual Coccidioidomycosis Study Group will take place April 5th-April 6th, 2024 in San…
READ MORE →
